Skip to content

Clinical trials

Completed Phase 2 Insulin Resistance trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 2 Status: Completed Clear all

171 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20022
20036
20047
20059
200612
200712
200819
20098
20105
20118
201210
201310
201412
201513
20164
20176
20182
20196
20204
20211
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed171

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut de Recherches Cliniques de Montreal13
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)9
University of Guadalajara8
Massachusetts General Hospital4
Tehran University of Medical Sciences4
Albert Einstein College of Medicine3
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
Halozyme Therapeutics3
Mayo Clinic3
Novartis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance171
Diabetes Mellitus, Type 230
Diabetes Mellitus29
Metabolic Syndrome29
Obesity28
Diabetes Mellitus, Type 127
Hypoglycemia16
Non-alcoholic Fatty Liver Disease12
Fatty Liver11
Glucose Intolerance11

Trials

Showing 1 to 25 of 171. Each trial links to its page on Pharma Observatory.

71 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.